leisure time -WSS

leisure time

author：comprehensive 2025-10-04 11:31:12 - browse：82746

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

WSS

A preacher's new calling: Diversifying neuroscience research

Merck to acquire Harpoon Therapeutics for $680 million

The pink breast cancer awareness ribbon needs a redesign

Merck to acquire Harpoon Therapeutics for $680 million

Cassava reveals details — and problems — with Alzheimer's study

Paying for Covid pills will soon shift to insurers

hotspot

leisure time

focus

United colonoscopy coverage change 'may cost lives,' doctors say

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

ChatGPT in medicine: STAT answers readers' burning questions

Meta's Zuckerberg and Chan on track to put $50 billion into science

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Eli Lilly to pay $200M for Beam’s stake in gene

Bright Health sells Medicare Advantage business to Molina

A preacher's new calling: Diversifying neuroscience research

Guidelines to prevent youth baseball injuries need more muscle

Why Sanofi got shellacked over its spinoff

focus

Does Paxlovid work in people vaccinated against Covid

STAT Virtual Event: JPM Recap, Live!

STAT Virtual Event: JPM Recap, Live!

JPM pitch from hospitals? Revenue streams outside of patient care

Telehealth options flood the market as retailers push virtual care

The pink breast cancer awareness ribbon needs a redesign

entertainment

hotspot

entertainment

hotspot